documents: EPA-HQ-OAR-2002-0095-0236
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OAR-2002-0095-0236 | EPA | EPA-HQ-OAR-2002-0095 | Letter to Paul Stolpman, USEPA, Office of Atmospheric Programs, from Jane Henney, M.D., Commissioner, U.S. Food and Drug Administration (FDA), regarding FDA determination on the amounts of chloroflurocarbons (CFCs) necessary for use in medical devices. [A-93-39-VIII-B-4] | Supporting & Related Material | Letter | 2022-07-21T04:00:00Z | 2022 | 7 | 2022-07-21T15:46:06Z | 0 | 0 | 0900006483d7e6da |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref